Drugs / Naoxintong Capsule
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01762163 Comparator | Oct 2013 → Oct 2016 | ischemic stroke | China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Naoxintong Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01762163 ↗ |
| Route | Oral | “Naoxintong Capsule was administered orally, four capsules each time, three times a day after each meal” NCT01762163 ↗ |